Paul Thomson

1.9k total citations
21 papers, 191 citations indexed

About

Paul Thomson is a scholar working on Pharmacology, Immunology and Pharmacology. According to data from OpenAlex, Paul Thomson has authored 21 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 13 papers in Immunology and 5 papers in Pharmacology. Recurrent topics in Paul Thomson's work include Drug-Induced Adverse Reactions (16 papers), Mast cells and histamine (7 papers) and Biosimilars and Bioanalytical Methods (4 papers). Paul Thomson is often cited by papers focused on Drug-Induced Adverse Reactions (16 papers), Mast cells and histamine (7 papers) and Biosimilars and Bioanalytical Methods (4 papers). Paul Thomson collaborates with scholars based in United Kingdom, United States and China. Paul Thomson's co-authors include Dean J. Naisbitt, Xiaoli Meng, Munir Pirmohamed, Monday O. Ogese, Anna Olsson‐Brown, Kanoot Jaruthamsophon, John Farrell, Chonlaphat Sukasem, Andrew Gibson and Arun Tailor and has published in prestigious journals such as The Journal of Immunology, Frontiers in Immunology and The Annual Review of Pharmacology and Toxicology.

In The Last Decade

Paul Thomson

17 papers receiving 184 citations

Peers

Countries citing papers authored by Paul Thomson

Since Specialization

Citations

This map shows the geographic impact of Paul Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Thomson more than expected).

Fields of papers citing papers by Paul Thomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Thomson. The network helps show where Paul Thomson may publish in the future.

Co-authorship network of co-authors of Paul Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Thomson. A scholar is included among the top collaborators of Paul Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Thomson. Paul Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity 2025 ·Signal Transduction and Targeted Therapy ·Lele Sun, Pengcheng Huai, Zhenzhen Wang, Qing Zhao, (unknown), Tingting Liu, Xiaotong Xue, (unknown), Jiabao You, Yonghu Sun, Zihao Mi, Joshua Gardner, Paul Thomson, Dean J. Naisbitt, Xiaoli Meng, Jianjun Liu, (unknown), Furen Zhang	0
2	Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS 2025 ·Toxicological Sciences ·Joshua Gardner, (unknown), (unknown), Paul Thomson, (unknown), Andrew Gibson, Matthew S. Krantz, Michael R. Ardern‐Jones, Elizabeth J. Phillips, Dean J. Naisbitt	0
3	The deglycosylated metabolite of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D- glucoside contributes to immune-mediated hepatotoxicity induced by Polygonum multiflorum 2025 ·Archives of Toxicology ·Ying Li, Yuwei Hu, Xiaoli Meng, Paul Thomson, Dongsheng Ouyang, Dean J. Naisbitt, Tai Rao	0
4	The role of regulatory T cells in preventing the development of drug hypersensitivity reactions 2025 ·Current Opinion in Allergy and Clinical Immunology ·(unknown), Megan Mitchell, Paul Thomson	1
5	Bioactivation of the β-Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor Atabecestat Leads to Protein Adduct Formation on Glutathione S-Transferase Pi 2025 ·Chemical Research in Toxicology ·Megan S. Ford, Paul Thomson, Adam Lister, Jan Snoeys, (unknown), Filip Cuyckens, Dean J. Naisbitt, Xiaoli Meng	0
6	Selective HLA Class II Allele-Restricted Activation of Atabecestat Metabolite-Specific Human T-Cells 2024 ·Chemical Research in Toxicology ·Megan S. Ford, Paul Thomson, Jan Snoeys, Xiaoli Meng, Dean J. Naisbitt	1
7	Activation of Human CD8+ T Cells with Nitroso Dapsone–Modified HLA-B13:01–Binding Peptides 2023 ·The Journal of Immunology* ·Mubarak Almutairi, Adam Lister, Qing Zhao, (unknown), (unknown), Arun Tailor, J. Waddington, (unknown), Joshua Gardner, Paul Thomson, (unknown), Yonghu Sun, Lele Sun, David A. Ostrov, Hong Liu, David J. MacEwan, Munir Pirmohamed, Xiaoli Meng, Furen Zhang, Dean J. Naisbitt	3
8	Patients with naproxen‐induced liver injury display T‐cell memory responses toward an oxidative (S)‐O‐desmethyl naproxen metabolite but not the acyl glucuronide 2023 ·Allergy ·Paul Thomson, (unknown), (unknown), Guruprasad P. Aithal, M. Isabel Lucena, Luigi Terracciano, Xiaoli Meng, Munir Pirmohamed, Dominique Brees, Gerd A. Kullak‐Ublick, Alex Odermatt, Thomas Hammond, Michael Kammüller, Dean J. Naisbitt	5
9	What’s been Hapten-ing over the last 88 years? 2023 ·Medicinal Chemistry Research ·Paul Thomson, (unknown), Xiaoli Meng, Dean J. Naisbitt	3
10	Characterization of Drug-Specific CD4⁺ T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions 2023 ·Chemical Research in Toxicology ·Kanoot Jaruthamsophon, Paul Thomson, (unknown), (unknown), Ana Alfirevic, Chonlaphat Sukasem, Dean J. Naisbitt, Munir Pirmohamed	4
11	Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility 2022 ·Current Opinion in Allergy and Clinical Immunology ·(unknown), Paul Thomson, Dean J. Naisbitt	4
12	Pathology of drug hypersensitivity reactions and mechanisms of immune tolerance 2022 ·Clinical & Experimental Allergy ·Paul Thomson, (unknown), Dean J. Naisbitt	5
13	Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B13:01 2021 ·Frontiers in Immunology* ·(unknown), Paul Thomson, Kanoot Jaruthamsophon, (unknown), (unknown), Ticha Rerkpattanapipat, Wichittra Tassaneeyakul, Nontaya Nakkam, Pawinee Rerknimitr, Jettanong Klaewsongkram, Yuttana Srinoulprasert, Munir Pirmohamed, Dean J. Naisbitt, Chonlaphat Sukasem	16
14	T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab 2021 ·Journal for ImmunoTherapy of Cancer ·(unknown), Anna Olsson‐Brown, Joshua Gardner, Paul Thomson, (unknown), (unknown), Daniel F. Carr, Lorenzo Ressel, Munir Pirmohamed, Dean J. Naisbitt	14
15	HLA Allele–Restricted Immune-Mediated Adverse Drug Reactions: Framework for Genetic Prediction 2021 ·The Annual Review of Pharmacology and Toxicology ·Kanoot Jaruthamsophon, Paul Thomson, Chonlaphat Sukasem, Dean J. Naisbitt, Munir Pirmohamed	19
16	In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs 2021 ·Frontiers in Immunology ·(unknown), Paul Thomson, Xiaoli Meng, Dean J. Naisbitt	18
17	Drug‐specific T‐cell responses in patients with liver injury following treatment with the BACE inhibitor atabecestat 2020 ·Allergy ·Paul Thomson, (unknown), Xiaoli Meng, Jan Snoeys, An De Bondt, Dries De Maeyer, Hans Wils, Laurent Leclercq, Petra Vinken, Dean J. Naisbitt	15
18	Immune dysregulation increases the incidence of delayed‐type drug hypersensitivity reactions 2019 ·Allergy ·Dean J. Naisbitt, Anna Olsson‐Brown, Andrew Gibson, Xiaoli Meng, Monday O. Ogese, Arun Tailor, Paul Thomson	27
19	Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA‐B57:01 binding and T‐cell activation 2019 ·Allergy* ·Paul Thomson, Patricia T. Illing, John Farrell, (unknown), Catherine C. Bell, Neil G. Berry, Paul M. O’Neill, Anthony W. Purcell, Kevin B. Park, Dean J. Naisbitt	19
20	From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury 2016 ·Toxicological Sciences ·Toru Usui, Xiaoli Meng, (unknown), John Farrell, Paul Thomson, Paul Whitaker, J. W. Watson, Neil French, (unknown), Dean J. Naisbitt	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact